Unlock the Power of AI for Life Science: Paige’s Revolutionary Approach
Paige, a digital pathology and AI leader, has introduced a service line powered by its Foundation Models. These models...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Authority FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Protocol Design Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Paige, a digital pathology and AI leader, has introduced a service line powered by its Foundation Models. These models...
Heart failure, which affects 90,000 Irish citizens, poses a significant burden on healthcare systems. Dublin-based FIRE1 has made a...
Bristol Myers Squibb has garnered FDA approval for Breyanzi, a CAR-T cell therapy for relapsed or refractory mantle cell...
Late-breaking results from the KONFIDENT phase 3 and open-label KONFIDENT-S extension trials were presented at the European Academy of...
Artera’s multimodal artificial intelligence (MMAI) platform has demonstrated notable prognostic value in prostate and early-stage breast cancer. Studies presented...
Calidi Biotherapeutics, a biotechnology company focusing on targeted immunotherapies, announced the exercise of warrants for purchasing over 10.6 million...
The European Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for LIVMARLI (maralixibat) oral...
The EVOKE-01 study investigated Trodelvy against docetaxel in patients with advanced non-small cell lung cancersmall cell lung cancer (NSCLC)...
A recent Phase 3 CROWN trial has demonstrated the long-term effectiveness of LORBRENA in treating ALK-positive advanced non-small cell...
Ensuring consistency and accuracy in data collection through digital health technology (DHT) is paramount in the rapidly evolving landscape...